Rollins stock performance context

Rollins (ROL) has been on investors’ radar after a period where the stock is down about 11% over the past month and 14% over the past 3 months, despite steady pest control operations.

At a share price of $47.19, Rollins has seen its recent momentum fade, with the 30 day share price return down 10.66% and year to date share price return down 20.03%. However, the 5 year total shareholder return of 52.16% still reflects solid longer term outcomes.

If Rollins’s recent pullback has you reassessing your watchlist, it could be a good moment to widen the search and check out 20 top founder-led companies

With Rollins trading at $47.19 while analyst targets sit higher and intrinsic value estimates are close by, you need to ask whether the recent slide leaves meaningful upside on the table or whether the market already sees future growth clearly priced in.

Most Popular Narrative: 140.4% Overvalued

Rollins last closed at $47.19, while the most followed narrative, using a fair value of $19.63 at a 6.98% discount rate, points to a much lower figure.

Rollins is the dominant pure-play compounder in global pest control, a structurally necessary, recession-resistant service business that has grown revenue for 24 consecutive years and delivered ROIC of 23 to 31% for 12 consecutive years, without a single year of ROIC below 21% even through COVID-19. The investment thesis rests on three mutually reinforcing pillars: (1) a Wide Moat rooted in switching costs, as commercial customers cannot switch providers without triggering compliance risk, and residential customers renew habitually at annual price increases of 3 to 4% above CPI without meaningful churn; (2) a proven M&A flywheel that converts a fragmented industry of more than 34,000 U.S. operators into compounding route density and FCF, completing 30 to 45 bolt-on acquisitions annually at disciplined multiples with zero reported impairments; and (3) a capital-light business model with minimal reinvestment needs, generating FCF of $678M in FY2025 on $3.76B of revenue.

According to Esteban, the fair value hinges on how fast revenue climbs, how free cash flow scales off that base, and what multiple Rollins could ultimately support.

Result: Fair Value of $19.63 (OVERVALUED)

However, if acquisition returns weaken or pest control demand softens in key end markets, such as healthcare and food service, that fair value narrative could unravel.

Next Steps

With mixed signals across price action, valuation narratives and business quality, it makes sense to look at the full picture quickly and form your own stance, including how investors are weighing up 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Rollins has sharpened your thinking, do not stop there. Use the Screener to spot other opportunities that could fit your style before the crowd moves.

• Target stability by focusing on companies that show financial resilience with the 70 resilient stocks with low risk scores.
• Hunt for value by zeroing in on quality stocks that appear attractively priced using the 44 high quality undervalued stocks.
• Back durable balance sheets by filtering for companies with strong financial footing through the solid balance sheet and fundamentals stocks screener (48 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.